MEDRAD’s Intego™ PET Infusion System has been named one of Medical Imaging Magazine’s top eight most innovative products of the year.  The magazine designated its top eight based on what its readership considers to be the most far-reaching, game changing or otherwise groundbreaking medical devices on the market.

MEDRAD’s Intego PET Infusion System automatically measures and delivers patient-specific Fluorodeoxyglucose (FDG) doses on demand.  With on-board dosimetry, the system can deliver precise, repeatable FDG doses within +/- 2% of the measured dose.  The Intego also minimizes FDG handling and is fully shielded, reducing radiation exposure by more than 20% compared to conventional (syringe-based) FDG delivery methods.  

”Intego technology is raising the standard of care in FDG delivery,” says Doug Descalzi, Executive Director of MEDRAD’s Molecular Imaging business.  “Healthcare professionals gain precision, flexibility and control over workflow, which can help any PET practice grow clinically and safely.”

More detailed information on MEDRAD’s Intego PET Infusion System is available at http://www.medrad.com/FDGdelivery